Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated just now
Peer-reviewedCC BY 4.0PLOS One

Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023–2024

4 affiliations
  1. 1Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna, Sweden
  2. 2ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
  3. 3Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden
  4. 4Department of Aquatic Sciences and Assessment, Science for Life Laboratory, Swedish University of Agricultural Sciences, Uppsala, Sweden

Abstract

Wastewater surveillance (WWS) of SARS-CoV-2 RNA levels offers a way to monitor virus circulation independently of clinical testing. With COVID-19 now endemic, clarifying the role of WWS within routine surveillance is essential. The aim was to evaluate the potential of WWS as an early warning indicator for COVID-19 in Sweden, based on its correlation with reported case data. The study includes data from July 2023 to December 2024, from 19 wastewater treatment plants (WWTPs), covering 43% of Sweden’s population, and surveillance data of reported COVID-19 cases. Analyses were performed by WWTP, separately for Stockholm (4 WWTPs) and at a national level (19 WWTPs). We compared wastewater SARS-CoV-2 levels to reported COVID-19 cases using cross-correlation and prediction metrics following trend classification. Correlations and classification metrics were highest without time shifts. SARS-CoV-2 levels in wastewater were strongly correlated with reported COVID-19 cases, with median cross-correlation values of 0.80 across all WWTPs and 0.87 at Stockholm and national levels. Positive predictive values of wastewater data to reported cases ranged from 63–74%, and negative predictive values from 85–95%. Sensitivity and specificity in Stockholm reached 78% and 87%; at national level, 72% and 84%, respectively. Under the evaluated weekly sampling and reporting system, WWS did not demonstrate a consistent early-warning advantage over reported cases but may support monitoring of trends when clinical testing is reduced.

Related

  1. WingShape-Warn: A Morphology-Driven Early-Warning Pipeline for Mosquito-Borne Disease Surveillance
    Yanrui Chen, Xue Wang, Tao Jiang +1
    InsectsPeer-reviewedCC BYFull textGeneral biologyEurope PMC
  2. Early-warning surveillance of West Nile and Usutu viruses in wetland and larval habitat waters and in mosquito excreta using digital PCR
    Julien Mocq, Julie Raymond, Karine Bolloré +11
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BYFull textZoology & animal behaviourInfectious diseasePLOSEurope PMC
  3. Multimodal genomic surveillance for respiratory pathogens at four U.S. international airports: A comparison of air, wastewater, clinical, and national surveillance data
    Dawn Gratalo, Cindy R. Friedman, Valerie J. Morley +11
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full textGenetics & genomicsMicrobiologyPLOS
  4. Epidemiological trends of Fusarium wilt in chickpea and its management through ICT-enabled surveillance in Maharashtra
    S. Niranjan, M. Meenakshi, K. Rakesh +6
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPlant biologyCrossref
  5. Directions for wastewater-based surveillance in Europe – insights from the EU-WISH 2025 International Workshop
    Anna Kildemoes, Wim G Meijer, Blandine Fauvel +41
    Open Research EuropePeer-reviewedCC BY 4.0Full textGeneral biologyEpidemiology & public healthHAL
BibTeX
@article{ohlson2026evaluation,
  title = {{Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023–2024}},
  author = {Anna Ohlson and Moa Rehn and Sharon Kühlmann Berenzon and Erik Sturegård and Rakel Brodin and Anna J. Székely and Sofia Persson and Ilias Galanis},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0358326},
  url = {https://doi.org/10.1371/journal.pone.0358326},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023–2024
AU  - Anna Ohlson
AU  - Moa Rehn
AU  - Sharon Kühlmann Berenzon
AU  - Erik Sturegård
AU  - Rakel Brodin
AU  - Anna J. Székely
AU  - Sofia Persson
AU  - Ilias Galanis
PY  - 2026
DA  - 2026/09/21
JO  - PLOS One
DO  - 10.1371/journal.pone.0358326
UR  - https://doi.org/10.1371/journal.pone.0358326
AB  - Wastewater surveillance (WWS) of SARS-CoV-2 RNA levels offers a way to monitor virus circulation independently of clinical testing. With COVID-19 now endemic, clarifying the role of WWS within routine surveillance is essential. The aim was to evaluate the potential of WWS as an early warning indicator for COVID-19 in Sweden, based on its correlation with reported case data. The study includes data from July 2023 to December 2024, from 19 wastewater treatment plants (WWTPs), covering 43% of Sweden’s population, and surveillance data of reported COVID-19 cases. Analyses were performed by WWTP, separately for Stockholm (4 WWTPs) and at a national level (19 WWTPs). We compared wastewater SARS-CoV-2 levels to reported COVID-19 cases using cross-correlation and prediction metrics following trend classification. Correlations and classification metrics were highest without time shifts. SARS-CoV-2 levels in wastewater were strongly correlated with reported COVID-19 cases, with median cross-correlation values of 0.80 across all WWTPs and 0.87 at Stockholm and national levels. Positive predictive values of wastewater data to reported cases ranged from 63–74%, and negative predictive values from 85–95%. Sensitivity and specificity in Stockholm reached 78% and 87%; at national level, 72% and 84%, respectively. Under the evaluated weekly sampling and reporting system, WWS did not demonstrate a consistent early-warning advantage over reported cases but may support monitoring of trends when clinical testing is reduced.
SN  - 1932-6203
ER  -